Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo

Kunimitsu Kanai, Eiji Kikuchi, Shuji Mikami, Eriko Suzuki, Yasumitsu Uchida, Kiichiro Kodaira, Akira Miyajima, Takashi Ohigashi, Jun Nakashima, Mototsugu Oya

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

There have been several studies on the antitumor activities of vitamin E succinate (α-TOS) as complementary and alternative medicine. In the present study, we investigated the cytotoxic effect of α-TOS and the enhancement of chemosensitivity to paclitaxel by α-TOS in bladder cancer. KU-19-19 and 5637 bladder cancer cell lines were cultured in α-TOS and/or paclitaxel in vitro. Cell viability, flow cytometric analysis, and nuclear factor-kappa B (NF-γB) activity were analyzed. For in vivo therapeutic experiments, pre-established KU-19-19 tumors were treated with α-TOS and/or paclitaxel. In KU-19-19 and 5637 cells, the combination treatment resulted in a significantly higher level of growth inhibition, and apoptosis was significantly induced by the combination treatment. NF-γB was activated by paclitaxel; however, the activation of NF-γB was inhibited by α-TOS. Also, the combination treatment significantly inhibited tumor growth in mice. In the immunostaining of the tumors, apoptosis was induced and proliferation was inhibited by the combination treatment. Combination treatment of α-TOS and paclitaxel showed promising anticancer effects in terms of inhibiting bladder cancer cell growth and viability in vitro and in vivo. One of the potential mechanisms by which the combination therapy has synergistic cytotoxic effects against bladder cancer may be that α-TOS inhibits NF-γB induced by chemotherapeutic agents.

Original languageEnglish
Pages (from-to)216-223
Number of pages8
JournalCancer Science
Volume101
Issue number1
DOIs
Publication statusPublished - 2010 Jan

Fingerprint

Succinic Acid
Paclitaxel
Vitamin E
Urinary Bladder Neoplasms
Apoptosis
NF-kappa B
Complementary Therapies
Therapeutics
Cell Survival
Growth
Neoplasms
In Vitro Techniques
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo. / Kanai, Kunimitsu; Kikuchi, Eiji; Mikami, Shuji; Suzuki, Eriko; Uchida, Yasumitsu; Kodaira, Kiichiro; Miyajima, Akira; Ohigashi, Takashi; Nakashima, Jun; Oya, Mototsugu.

In: Cancer Science, Vol. 101, No. 1, 01.2010, p. 216-223.

Research output: Contribution to journalArticle

Kanai, Kunimitsu ; Kikuchi, Eiji ; Mikami, Shuji ; Suzuki, Eriko ; Uchida, Yasumitsu ; Kodaira, Kiichiro ; Miyajima, Akira ; Ohigashi, Takashi ; Nakashima, Jun ; Oya, Mototsugu. / Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo. In: Cancer Science. 2010 ; Vol. 101, No. 1. pp. 216-223.
@article{db6049469e8a4a7abe9fcc62b6c3b0f8,
title = "Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo",
abstract = "There have been several studies on the antitumor activities of vitamin E succinate (α-TOS) as complementary and alternative medicine. In the present study, we investigated the cytotoxic effect of α-TOS and the enhancement of chemosensitivity to paclitaxel by α-TOS in bladder cancer. KU-19-19 and 5637 bladder cancer cell lines were cultured in α-TOS and/or paclitaxel in vitro. Cell viability, flow cytometric analysis, and nuclear factor-kappa B (NF-γB) activity were analyzed. For in vivo therapeutic experiments, pre-established KU-19-19 tumors were treated with α-TOS and/or paclitaxel. In KU-19-19 and 5637 cells, the combination treatment resulted in a significantly higher level of growth inhibition, and apoptosis was significantly induced by the combination treatment. NF-γB was activated by paclitaxel; however, the activation of NF-γB was inhibited by α-TOS. Also, the combination treatment significantly inhibited tumor growth in mice. In the immunostaining of the tumors, apoptosis was induced and proliferation was inhibited by the combination treatment. Combination treatment of α-TOS and paclitaxel showed promising anticancer effects in terms of inhibiting bladder cancer cell growth and viability in vitro and in vivo. One of the potential mechanisms by which the combination therapy has synergistic cytotoxic effects against bladder cancer may be that α-TOS inhibits NF-γB induced by chemotherapeutic agents.",
author = "Kunimitsu Kanai and Eiji Kikuchi and Shuji Mikami and Eriko Suzuki and Yasumitsu Uchida and Kiichiro Kodaira and Akira Miyajima and Takashi Ohigashi and Jun Nakashima and Mototsugu Oya",
year = "2010",
month = "1",
doi = "10.1111/j.1349-7006.2009.01362.x",
language = "English",
volume = "101",
pages = "216--223",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo

AU - Kanai, Kunimitsu

AU - Kikuchi, Eiji

AU - Mikami, Shuji

AU - Suzuki, Eriko

AU - Uchida, Yasumitsu

AU - Kodaira, Kiichiro

AU - Miyajima, Akira

AU - Ohigashi, Takashi

AU - Nakashima, Jun

AU - Oya, Mototsugu

PY - 2010/1

Y1 - 2010/1

N2 - There have been several studies on the antitumor activities of vitamin E succinate (α-TOS) as complementary and alternative medicine. In the present study, we investigated the cytotoxic effect of α-TOS and the enhancement of chemosensitivity to paclitaxel by α-TOS in bladder cancer. KU-19-19 and 5637 bladder cancer cell lines were cultured in α-TOS and/or paclitaxel in vitro. Cell viability, flow cytometric analysis, and nuclear factor-kappa B (NF-γB) activity were analyzed. For in vivo therapeutic experiments, pre-established KU-19-19 tumors were treated with α-TOS and/or paclitaxel. In KU-19-19 and 5637 cells, the combination treatment resulted in a significantly higher level of growth inhibition, and apoptosis was significantly induced by the combination treatment. NF-γB was activated by paclitaxel; however, the activation of NF-γB was inhibited by α-TOS. Also, the combination treatment significantly inhibited tumor growth in mice. In the immunostaining of the tumors, apoptosis was induced and proliferation was inhibited by the combination treatment. Combination treatment of α-TOS and paclitaxel showed promising anticancer effects in terms of inhibiting bladder cancer cell growth and viability in vitro and in vivo. One of the potential mechanisms by which the combination therapy has synergistic cytotoxic effects against bladder cancer may be that α-TOS inhibits NF-γB induced by chemotherapeutic agents.

AB - There have been several studies on the antitumor activities of vitamin E succinate (α-TOS) as complementary and alternative medicine. In the present study, we investigated the cytotoxic effect of α-TOS and the enhancement of chemosensitivity to paclitaxel by α-TOS in bladder cancer. KU-19-19 and 5637 bladder cancer cell lines were cultured in α-TOS and/or paclitaxel in vitro. Cell viability, flow cytometric analysis, and nuclear factor-kappa B (NF-γB) activity were analyzed. For in vivo therapeutic experiments, pre-established KU-19-19 tumors were treated with α-TOS and/or paclitaxel. In KU-19-19 and 5637 cells, the combination treatment resulted in a significantly higher level of growth inhibition, and apoptosis was significantly induced by the combination treatment. NF-γB was activated by paclitaxel; however, the activation of NF-γB was inhibited by α-TOS. Also, the combination treatment significantly inhibited tumor growth in mice. In the immunostaining of the tumors, apoptosis was induced and proliferation was inhibited by the combination treatment. Combination treatment of α-TOS and paclitaxel showed promising anticancer effects in terms of inhibiting bladder cancer cell growth and viability in vitro and in vivo. One of the potential mechanisms by which the combination therapy has synergistic cytotoxic effects against bladder cancer may be that α-TOS inhibits NF-γB induced by chemotherapeutic agents.

UR - http://www.scopus.com/inward/record.url?scp=71849097159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849097159&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2009.01362.x

DO - 10.1111/j.1349-7006.2009.01362.x

M3 - Article

C2 - 19824995

AN - SCOPUS:71849097159

VL - 101

SP - 216

EP - 223

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 1

ER -